Enzymatic Synthesis of NAD +
Current Protocols · 2026-06 · 6 (6)
DOI: 10.1002/cpz1.70397 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Protocols, online erschienen am 08.06.2026. Verfasst von Emily Boyle und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA, USA. Hauptthemen laut MEDLINE: NAD. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH/NIGMS, George and Lavinia Blick Research Fund.
Abstract (Originalsprache)
Nicotinamide adenine dinucleotide (NAD + ) is an essential metabolite involved in numerous biological processes, functioning both as a redox cofactor in cellular energy metabolism and as a co‐substrate for NAD + ‐utilizing enzymes, including sirtuins and poly(ADP‐ribose) polymerases. Given its central role in maintaining physiological homeostasis and its involvement in a wide range of disease processes, there is growing interest in developing NAD + and its analogs as chemical probes and potential therapeutic agents. However, the chemical synthesis of NAD + analogs is often hampered by low yields, poor stereoselectivity, and the formation of undesired byproducts. In contrast, enzymatic synthesis offers a more efficient and selective strategy using readily available starting materials under mild conditions. Herein, we report a two‐step enzymatic strategy for the synthesis of NAD + . In the first step, a ten‐enzyme coupled reaction cascade converts glucose into nicotinic acid adenine dinucleotide (NaAD). In the second step, the isolated NaAD is subsequently converted to NAD + by NAD + synthetase. This modular enzymatic platform provides an efficient, scalable approach to NAD + production and establishes a versatile foundation for the biosynthesis of NAD + analogs for biochemical and biomedical applications. © 2026 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1 : Transformation of plasmid DNA into Rosetta(DE3) cells Basic Protocol 2 : Recombinant expression, purification, and activity assessment of NMA1 Basic Protocol 3 : Recombinant expression, purification, and activity assessment of Ta 1145 Basic Protocol 4 : Recombinant expression, purification, and activity assessment of PrsA Basic Protocol 5 : Two‐step enzymatic synthesis of NAD +
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA, USA.
- Maggie L Walker Governor's School, Richmond, VA, USA.
- Center for Drug Discovery, Virginia Commonwealth University, Richmond, VA, USA.
Förderung
- NIH/NIGMS
- George and Lavinia Blick Research Fund
Zitieren
APA
Boyle, E., Zhang, O., & Cen, Y. (2026). Enzymatic Synthesis of NAD +. Current Protocols, 6(6). https://doi.org/10.1002/cpz1.70397
Vancouver
Boyle E, Zhang O, Cen Y. Enzymatic Synthesis of NAD +. Current Protocols. 2026;6(6). doi:10.1002/cpz1.70397
BibTeX
@article{Boyle2026,
author = {Boyle, Emily and Zhang, Olivia and Cen, Yana},
title = {Enzymatic Synthesis of NAD +},
journal = {Current Protocols},
year = {2026},
volume = {6},
number = {6},
doi = {10.1002/cpz1.70397}
}
EUVIMED